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I N T R O D U C T I O N
It is now well established that there is a tonic form of inhibition that can modulate neuronal excitability (Brickley et al. 1996; Cavelier et al. 2005; Hamann et al. 2002; Nusser and Mody 2002; Rossi et al. 2003; Semyanov et al. 2004; Soltesz and Nusser 2001) and that this is caused by activation of high-affinity, extrasynaptic GABA A receptors (Brickley et al. 1999 (Brickley et al. , 2001 Mody 2001; Rossi and Hamann 1998; Stell and Mody 2002; Stell et al. 2003) by the low levels of ambient GABA normally present in the brain (Lerma et al. 1986; Tossman et al. 1986 ). The source of GABA responsible for tonic inhibition, however, remains unclear. The most common explanation is that some of the GABA released into the synaptic cleft on vesicular fusion is not recovered by GABA transporters. It escapes from the synapse and diffuses to extrasynaptic sites. It is likely that this "spillover" (Isaacson et al. 1993; Rossi and Hamann 1998) does occur, given observations that tonic inhibition is often increased in response to pharmacological blockade of GAT1 (Keros and Hablitz 2005; Overstreet and Westbrook 2001; Rossi et al. 2003; Semyanov et al. 2003 Semyanov et al. , 2004 Wall and Usowicz 1997) , and is greater in slices prepared from GAT1 knockout mice (Chiu et al. 2005; Jensen et al. 2003) . However, it is also likely that there are additional nonvesicular sources of GABA because tonic inhibition can still occur after blocking vesicular GABA release with tetanus toxin, concanamycin, or removal of extracellular calcium (Hamann et al. 2002; Rossi et al. 2003; Wu et al. 2001 Wu et al. , 2003 .
It has recently been proposed that GABA transporters help determine the level of tonic inhibition by attempting to clamp ambient [GABA] at the level at which transporters are at equilibrium (Richerson and Wu 2003) . This equilibrium is determined by the stoichiometry of GABA transporters. GAT1 translocates two sodium ions, one chloride ion, and one uncharged GABA molecule with each thermodynamic reaction cycle. Because of this stoichiometry, it is predicted that GAT1 is near equilibrium under normal physiological conditions and would reverse with a relatively small increase in membrane potential or cytosolic [GABA] (Richerson and Wu 2003) . In support of this hypothesis, there is a large increase in tonic GABA current in rat hippocampal cultures that have been depolarized with a small increase in extracellular [K ϩ ] or that have been treated with the GABA transaminase inhibitor vigabatrin, which increases cytosolic [GABA] . In both cases the increase in tonic current is not prevented by blocking vesicular GABA release, and is decreased by GABA transporter antagonists (Wu et al. 2001 (Wu et al. , 2003 .
Here we used cultured hippocampal neurons and found that there was a significant amount of tonic GABA current in the absence of vigabatrin treatment. The amount of tonic current was unaffected by removing extracellular Ca 2ϩ but was decreased by blocking GAT1. The amount of tonic current was sensitive to the transmembrane sodium gradient-increasing in response to manipulations that decrease the normally inward sodium gradient and decreasing in response to others that increase the inward sodium gradient. Similar results were obtained in slices, except that a GAT1-independent nonvesicular mechanism was found to play a larger role in GABA release. We conclude that when vesicular GABA release is reduced, GABA transporters will reverse in an attempt to reach digitized (at 200 samples/s), and stored on computer using a commercially available data acquisition system (Digidata 1322A and PClamp software, Axon Instruments). Those in Fig. 1C and Fig. 2 were filtered at 1 KHz and sampled at 2,000 samples/s.
Sources for chemicals
Neurobasal medium, B27 supplement, and bFGF were purchased from Gibco BRL Products (Gaithersburg, MD). MEM was purchased from JRH Biosciences (Lenexa, KS). QX-314 and TTX were purchased from Alomone Labs (Jerusalem, Israel). SKF-89976a and CGP-55845 were purchased from Tocris Cookson (Ballwin, MO). Veratridine, kynurenic acid, AP-5, CNQX, bicuculline methiodide, gabazine, SNAP-5114, FBS, FGF-5, and all other chemicals not listed were purchased from Sigma Chemical (St. Louis, MO).
Data analysis
Tonic GABA A receptor-mediated current was quantified by measuring the change in holding current induced after exchanging the bath solution with one that contained bicuculline methiodide (50 M) or gabazine (10 M). Commercially available software (Clampfit, Axon Instruments) was used to subtract the baseline holding current from the steady-state current during bicuculline or gabazine application to obtain the mean GABA A receptor-mediated current. During recordings with calcium, tonic current was calculated using baseline current measured between inhibitory postsynaptic currents (IPSCs). When miniature IPSCs occurred, there was no attempt to measure tonic current between these mIPSCs, but the error in measurement of the tonic current in normal calcium Ringer ranged from 0 to 20 pA. This error was even smaller for zero Ca 2ϩ Ringer (see RESULTS). Probability values were determined using a Mann-Whitney rank sum test (SigmaStat). NS refers to a difference that is not statistically significant. Values expressed as "n" are the total number of neurons recorded. All values are means Ϯ SE, and all error bars are SE.
R E S U L T S

Tonic inhibitory current occurred spontaneously in hippocampal cultures and was caused in part by reversal of the GABA transporter
We have previously shown in hippocampal cultures that vigabatrin induces a large amount of nonvesicular GABA release that is mediated in part by reversal of GABA transporters (Wu et al. 2001 (Wu et al. , 2003 . Here we performed similar experiments and found that there was also GABA-mediated tonic current in hippocampal cultures naïve to drug treatment. During gramicidin (n ϭ 2) and amphotericin (n ϭ 3) perforatedpatch recordings in which the electrode solution contained 5 mM KCl, gabazine (n ϭ 2) and bicuculline (n ϭ 3) blocked an outward, or inhibitory, current at a holding potential of -40 mV (Fig. 1A, top) . As in vigabatrin-treated cultures (Wu et al. 2001 (Wu et al. , 2003 , the GAT1 antagonist SKF-89976a (40 M) partially decreased the tonic current (Fig. 1A, bottom) by an average of 76% (n ϭ 5), indicating that it was caused in part by nonvesicular GABA release through reversal of GAT1. To be certain that the tonic current was inhibitory under our experimental conditions, these recordings were repeated (n ϭ 5) using gramicidin perforated-patch recordings containing 135 mM KCl. Gramicidin is permeable to monovalent cations, but not to chloride, so that neurons maintain their normal cytosolic [Cl Ϫ ]. Therefore if an outward current is blocked by bicuculline that would indicate that the reversal potential for GABA A receptors is more negative than the holding potential and that GABA would induce an inhibitory current. The use of a high [Cl Ϫ ] in the pipette guards against inadvertent breakthrough of the perforated patch, because if that occurred then GABA A receptor activation would be depolarizing. Under these conditions, bicuculline decreased a tonic outward current during voltage-clamp recordings (holding potential ϭ Ϫ50 mV; Fig.  1B ; n ϭ 5) and led to an increase in action potential firing during current-clamp recordings ( Fig. 1C; n ϭ 5) .
When whole cell voltage-clamp recordings were made in Ringer containing 2 mM calcium, bicuculline induced a decrease in tonic current in most neurons (Fig. 1D) . In this case, the current was inward, because the electrode solution contained a high [Cl Ϫ ]. The amplitude of this current did not change in response to removal of extracellular Ca 2ϩ (Fig. 1E ). On average, the amplitude of tonic current in 19 neurons (age ϭ 41 Ϯ 1 DIV) recorded in 2 mM Ca 2ϩ was 167 Ϯ 25 pA, and it was 163 Ϯ 11 pA in the same neurons in zero Ca 2ϩ solution (NS; Fig. 1F ). These results are similar to those seen previously in slices from the cerebellum after vesicular release was decreased by removal of extracellular Ca 2ϩ or depletion of vesicular GABA with concanamycin (Hamann et al. 2002; Rossi et al. 2003) .
Zero calcium Ringer solution blocked evoked IPSCs and significantly reduced spontaneous synaptic events
To confirm that zero Ca 2ϩ solution was effective in reducing vesicular GABA release, recordings were made from pairs of synaptically-coupled neurons in culture after blocking glutamate receptors with CNQX and AP-5. In a subset of recordings, stimulation of presynaptic neurons induced an outward current in postsynaptic neurons that was blocked by bicuculline (50 M; n ϭ 8). In 39 neurons, a postsynaptic response was induced by stimulating action potentials in the presynaptic neuron at 20 -50 Hz, and in all 39 cases, these IPSCs were completely blocked by changing the bath solution to zero Ca 2ϩ solution ( Fig. 2A) . Llano et al. (2000) have reported that mIPSCs can occur in cerebellar Purkinje cells in the absence of extracellular calcium. We also observed mIPSCs in zero Ca 2ϩ solution with TTX in cultured hippocampal neurons. However, the frequency of synaptic events was much lower than it was in normal Ringer. Changing bath solution from normal Ringer (with 2 mM Ca 2ϩ ) to zero Ca 2ϩ Ringer significantly reduced the number of postsynaptic events to 25 Ϯ 3% of control and the total charge transfer to 18 Ϯ 3% of control (n ϭ 10 neurons; age ϭ 26 Ϯ 2 DIV). Comparing recordings (Fig. 2, B and C) and amplitude histograms (Fig. 2D) under the two conditions revealed that removing extracellular Ca 2ϩ had a greater effect on larger events-probably IPSCs mediated by calcium influx during action potentials. Consistent with this assumption, TTX (0.4 M) had little additional effect on the frequency or size distribution of synaptic events (Fig. 2, B-D) . The frequency of synaptic events in zero calcium solution with TTX was 104 Ϯ 15% of that in zero calcium solution (NS), and the total charge transfer was 120 Ϯ 23% (NS).
Amplitude of tonic current increased with age in culture
The size of the response to bicuculline was dependent on the number of days that neurons were grown in culture (Fig. 3) . This increase in tonic current was caused in part by an increase control conditions. This result is in contrast to our previous experiments using a similar approach, in which it was necessary to pretreat cells with vigabatrin to induce a significant amount of tonic current in rat hippocampal cultures (Wu et al. 2001) . The previous experiments were done in cultures that were younger than those used here, and recordings were made in Ringer that contained TTX. The experiments presented here that showed a decrease in tonic current with TTX and younger age (Figs. 3 and 4) suggest that these two differences may account for the smaller amount of tonic current in those previous experiments.
Role of spillover as a source of GABA for tonic inhibition
The tonic current that we recorded in culture was not dependent on extracellular Ca 2ϩ . In previous work, tonic inhibition in cerebellar slices was also not reduced by removing extracellular calcium, by blocking release of calcium from intracellular stores, or by depleting vesicular GABA content with concanamycin (Hamann et al. 2002; Rossi et al. 2003) . Together, these results suggest that, in both preparations, continuous vesicular GABA release (i.e., spillover) is not essential as a source of ambient GABA for tonic inhibition.
Under normal conditions, spillover likely plays a major role as a source of ambient GABA. However, the data presented here suggest that when vesicular release is significantly reduced, GAT1 reversal can replace spillover in providing ambient GABA for tonic inhibition. This result is consistent with the hypothesis that GAT1 functions effectively in clamping extracellular [GABA] at the level at which GAT1 is at equilibrium (Richerson and Wu 2003) . When spillover occurs, GAT1 likely operates in the forward direction, but in its absence, GAT1 likely operates in reverse, in both cases regulating extracellular [GABA] at the same level.
These data do not address the relative contribution of GAT1 reversal in comparison to other forms of nonvesicular GABA release. In fact, our data suggest that other nonvesicular forms of GABA release do exist in our preparation (Richerson and Wu 2003; Wu et al. 2001 Wu et al. , 2005 , although the mechanisms these other forms of GABA release have not yet been defined.
Level of tonic current was sensitive to the transmembrane sodium gradient
The amount of tonic GABA current was decreased by TTX and increased by veratridine. As above, this was not caused by residual vesicular GABA release that was enhanced by veratridine or reduced by TTX, because evoked IPSCs had already been completely blocked by zero Ca 2ϩ solution and the infrequent synaptic events that remained were not affected by TTX (Fig. 2) . In addition, if veratridine did increase tonic current by stimulating vesicular release, then any IPSCs that were induced should have been observed, which was not the case.
The most likely explanation for the effect of TTX and veratridine was that they altered cytosolic [Na ϩ ] and membrane potential, and this changed the driving force on GABA transporters. There is experimental evidence that these manipulations can change [ (Shuai et al. 2003) . Thus the most likely explanation for the effect of TTX on tonic current is that [Na ϩ ] i was reduced and neurons were hyperpolarized, and this decreased the extracellular [GABA] at which GABA transporters are at equilibrium (Richerson and Wu 2003) . This is consistent with an earlier report that TTX can reduce tonic GABA current (Wall and Usowicz 1997) . It is frequently assumed that TTX induces a decrease in transmitter release solely because of blockade of synaptic activity, but the results obtained here indicate that caution should be used in making this conclusion, because TTX may also reduce transporter-mediated GABA release.
The response to veratridine may have an opposite explanation. Veratridine can increase cytosolic [Na ϩ ] (Rose and Ransom 1997) and causes depolarization, both of which would increase the extracellular [GABA] at which GABA transporters are at equilibrium (Richerson and Wu 2003) . Consistent with this conclusion, Szerb (1979) reported that 50 M veratridine induces nonvesicular GABA release from cortical slices.
Replacing sodium with NMDG in the absence of extracellular calcium also increased tonic GABA current. This could not be explained by stimulation of calcium-independent vesicular GABA release, because replacing Na ϩ with NMDG would block action potentials and hyperpolarize neurons. On the other hand, this manipulation would reverse the sodium gradient and cause an outward driving force on GABA transporters (Richerson and Wu 2003) . Removing extracellular Na ϩ would hyperpolarize neurons, which would reduce the outward driving force on GAT1, but would simultaneously reverse the [Na ϩ ] gradient, which would increase the outward driving force. Because this manipulation led to an increase in tonic current, it is apparent that changes in the [Na ϩ ] gradient can influence GABA transport independent of changes in membrane potential. Consistent with the observed decay of tonic current with prolonged exposure to zero sodium solution (Fig.  5) , GABA efflux should wane with time as intracellular Na ϩ (Onizuka et al. 2004; Rose and Ransom 1997) and GABA are depleted. Reversal of GABA transporters has previously been proposed as the mechanism for increased GABA release during ischemia in rats after sodium substitution with NMDG (Phillis et al. 1999 ).
Effect of changes in the [Na ϩ ] gradient on tonic GABA current in culture is through GAT1
Confirming that the increases in tonic current induced in culture by veratridine and zero sodium solution were mediated entirely by reversal of GAT1, they were both completely blocked by SKF-89976a. The dominant role of GAT1 reversal under these conditions might be caused by the fact that neurons are favored as the primary source of nonvesicular GABA release. GAT1 is present on glia (Conti et al. 2004; Kinney and Spain 2002; Minelli et al. 1995; Ribak et al. 1996; VitellaroZuccarello et al. 2003 ), but it is more heavily expressed in neurons. There is probably relatively little cytosolic GABA in glia at baseline, because of their high expression of GABA transaminase. Because vigabatrin blocks GABA transaminase, GABA efflux from glia may play a bigger role after treatment with vigabatrin (Wu et al. 2001 ). In fact, there is evidence that vigabatrin increases GABA release by both GAT1-dependent and GAT1-independent mechanisms (Wu et al. 2003 (Wu et al. , 2005 . However, the low [GABA] that would be expected in glia in the current paradigm would not favor GAT1-independent GABA release from glia. In addition, veratridine acts on fast transient sodium channels, which can be found on glia (Sontheimer et al. 1991) , but are more abundant on neurons. Veratridine increases cytosolic [Na ϩ ] in neurons (Rose and Ransom 1997) but has not been shown to alter cytosolic [Na ϩ ] in glia. For these reasons, there may be a larger effect of GAT1 blockade on tonic current in our culture protocol than would occur under other circumstances.
Comparison of tonic current in culture and brain slices
The major conclusions from the experiments in culture were supported by data from hippocampal slices. Ambient [GABA] was increased by veratridine and zero sodium solution, and the GABA release responsible for this was not calcium dependent. Thus tonic GABA current was modulated by changes in the transmembrane sodium gradient. This tonic GABA current depended in part on GAT1-mediated GABA release. We believe that the GABA release induced by veratridine in slices may have also come primarily from neurons, because veratridine raises intracellular [Na ϩ ] in neurons but not glia (Rose and Ransom 1997). In addition, Na ϩ channels and GAT1 are both expressed more on neurons than glia, and this GABA release was completely blocked by SKF-89976a.
There were also differences between brain slices and culture. For example, there was not a significant amount of tonic GABA current in slices at baseline. It was also much more difficult to exchange solution in brain slices, which was likely to be responsible for the need to use a higher concentration of veratridine in slices than in culture, the difficulty in getting full recovery from block by gabazine and SKF-89976a (Fig. 8) , and the differences in the kinetics of the response to zero sodium solution (Fig. 5 vs. Fig. 8 ).
Although some of these differences between slices and culture may have been simply methodological, there were also some differences suggesting that alternative mechanisms of tonic inhibition exist in slices. For example, SKF-89976a did not block nonvesicular GABA release induced by zero sodium solution in brain slices. Thus there is a GAT1-independent mechanism of nonvesicular GABA release in slices. There are many alternative mechanisms of nonvesicular release of neurotransmitters (Hell et al. 1991; Vautrin et al. 2000; Wang et al. 2002; Ye et al. 2003) , and several of these may be particularly relevant to brain slices, including GAT3 reversal (Kinney 2005; Kirmse and Kirischuk 2006) , swelling-activated anion channels (Kimelberg et al. 1990) , and leakage from damaged cells (Wall and Usowicz 1997) . For example, there is cell damage caused by trauma and ischemia during brain slice preparation, which could induce the latter two forms of release.
Alternatively, because normal neuron-glia interactions are better preserved in slices than in culture, glial release of GABA through GAT3 could be preserved more faithfully in slices. Our experiments showed that the GAT3 antagonist SNAP-5114 did not block the response to zero sodium solution (Fig.  8D) . We interpret these results as showing that GAT1 and GAT3 are not required for nonvesicular GABA release. It is possible that there is a contribution from GAT1 or GAT3 reversal (Kinney 2005; Kirmse and Kirischuk 2006), but neither of these are the sole mechanism of nonvesicular GABA release under these conditions. The mechanism of the additional source(s) of nonvesicular GABA release that is GAT1 and GAT3 independent remains unclear.
Physiological significance of the response of GABA transporters to the transmembrane sodium gradient
Some of the changes in sodium used here would not realistically occur under physiological conditions. However, they provide evidence that GABA transporters are influenced by the transmembrane sodium gradient and that changes in sodium concentration might alter the level of tonic inhibition under normal physiological conditions. In fact, because there are two sodium ions cotransported with each GABA molecule, the driving force on GAT1 is more steeply dependent on the sodium gradient than it is on either the GABA or chloride gradients or membrane potential. There is a small amount of sodium influx with each action potential, and during a burst of action potentials, there is an even greater rise in intracellular [Na ϩ ]. Thus even modest changes in neuronal activity would be expected to alter the driving force on GAT1 and may favor GAT1 reversal.
The influence of sodium levels on tonic GABA inhibition may be even greater under pathological conditions. When energy demand exceeds supply, such as during seizures or brain ischemia, there will be a reduction in activity of the Na/K ATPase. The resulting rise in intracellular [Na ϩ ] would be larger than during normal physiological activity, and this would be predicted to cause a large amount of nonvesicular GABA efflux. Thus it is likely that the effect of sodium on tonic inhibition defined here are relevant to brain function under physiological and/or pathological conditions.
GABA transporters regulate the level of tonic inhibition even when they do not reverse
It is not clear how commonly GABA transporters reverse in vivo. Under the conditions of these experiments, when vesicular release is blocked by zero calcium solution and extracellular GABA is continuously washed away by the flowing bath solution, it is more likely that GABA transporters would continuously operate in reverse in an attempt to bring extracellular [GABA] back up to the equilibrium level. However, even when GABA transporters are not reversing, they may still play an important role in regulating the amount of tonic inhibition. We believe that it is conceptually less important to determine whether GABA transporters are operating in the forward or reverse direction than to define the extracellular [GABA] at which GABA transporters are at their equilibrium. Based on both experimental evidence and theoretical modeling (Richerson and Wu 2003), GABA transporters can be viewed as attempting to clamp extracellular [GABA] at a level determined by the membrane potential and the transmembrane gradients of Na ϩ , Cl Ϫ , and GABA. If there is a large amount of vesicular GABA release, GABA transporters will operate in the forward direction, but only as much as is needed to drive extracellular [GABA] down to the level at which they are at equilibrium. If there is no vesicular GABA release, or there is significant clearance of GABA by some mechanism other than GABA transport (e.g., diffusion away from the tissue in vitro), GABA transporters will operate in reverse in an attempt to raise extracellular [GABA] to the equilibrium level. In this view, GABA transporters would play an important role in determining the level of tonic inhibition by regulating extracellular [GABA] , regardless of the direction of transport. We propose that GABA transporters attempt to clamp extracellular [GABA] at the level at which they are at or near their thermodynamic equilibrium, and under some conditions, this level is high enough to induce tonic inhibition. 
